Swissmedic Authorises New Therapeutic Use for Trecondi®
Swissmedic has announced an update regarding the medication Trecondi®. On October 31, 2025, the regulatory body extended the drug’s therapeutic […]
Swissmedic has announced an update regarding the medication Trecondi®. On October 31, 2025, the regulatory body extended the drug’s therapeutic […]
On October 31, 2025, Swissmedic announced the first authorisation of SWAN-PSMA-1007®, marking a significant regulatory milestone. This development is relevant
On October 31, 2025, Swissmedic and swissethics announced an update to their position paper on decentralised clinical trials (DCTs) for
Swissmedic has announced an important update regarding the therapeutic scope of Omvoh®. The newly approved indication offers enhanced application potential
Swissmedic has issued an announcement regarding the immediate recall of batch number 251347651 of NaCl B. Braun infusion solution. This
A new clinical trial is set to begin recruitment, aiming to improve medication adherence among adolescents and young adults living
On October 31, 2025, an exciting new clinical trial was announced that aims to address a critical health challenge—how to
Masimo Corporation has officially commenced recruitment for its clinical trial evaluating the accuracy of its irregular heartbeat detection algorithm in
Liquid Nitrogen Spray Cryotherapy (LNSC) combined with systemic therapy offers new hope for patients battling esophageal adenocarcinoma. A groundbreaking clinical
The CORUS-LX System is embarking on a critical phase of its journey to improve lumbar interbody fusion outcomes. As of